Christopher Glenn Mayne

USPTO Granted Patents = 3 (Patent Applications = 7)

CIPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 19.5

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

3 out of 4

Petra Pharma Corporation

patents

Years Active: 2023-2024

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11878970 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease (2024-01-23),

2. 11873295 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease (2024-01-16),

3. 11649227 - Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease (2023-05-16),

Title: The Inventor Christopher Glenn Mayne

Introduction: Christopher Glenn Mayne is a talented inventor based in Boulder, Colorado. His innovative spirit and dedication to creating new solutions have led to remarkable contributions in the field of technology.

Latest Patents: Christopher Glenn Mayne holds several patents in various technological areas, showcasing his versatility and creativity in inventing novel solutions to complex problems.

Career Highlights: Throughout his career, Christopher Glenn Mayne has been recognized for his groundbreaking inventions that have significantly impacted the tech industry. His passion for innovation has driven him to push the boundaries of what is possible.

Collaborations: Christopher Glenn Mayne has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work with diverse teams and leverage collective expertise has been instrumental in the success of his projects.

Conclusion: Christopher Glenn Mayne's relentless pursuit of innovation and his remarkable creativity make him a standout inventor in the tech world. His contributions continue to inspire and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.